Aclaris Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2024.
  • Aclaris Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.59M, a 74.1% increase year-over-year.
  • Aclaris Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$37M, a 67.7% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$88.5M, a 1.81% decline from 2022.
  • Aclaris Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$86.9M, a 4.36% increase from 2021.
  • Aclaris Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$90.9M, a 78.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$37M -$7.59M +$21.7M +74.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$58.7M -$11M +$18.6M +62.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-06
Q1 2024 -$77.3M -$16.9M +$11.2M +39.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-06
Q4 2023 -$88.5M -$1.49M +$26.1M +94.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$115M -$29.3M -$9.31M -46.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$105M -$29.6M -$9.04M -44% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-06
Q1 2023 -$96.3M -$28.2M -$9.37M -49.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-06
Q4 2022 -$86.9M -$27.6M -$4.83M -21.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$82.1M -$20M +$1.19M +5.65% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$83.3M -$20.5M -$2.37M -13.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$80.9M -$18.8M +$9.97M +34.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 -$90.9M -$22.8M -$9.63M -73.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$81.2M -$21.1M -$10.5M -98.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$70.7M -$18.2M -$6.56M -56.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$64.2M -$28.8M -$13.2M -84.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$51M -$13.2M +$5.42M +29.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$56.4M -$10.7M +$44.7M +80.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$101M -$11.6M +$38.3M +76.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 -$139M -$15.6M +$22M +58.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-02
Q4 2019 -$161M -$18.6M +$20M +51.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$181M -$55.3M -$22.6M -69% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$159M -$49.9M -$18.7M -59.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-04
Q1 2019 -$140M -$37.6M -$7.34M -24.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-04
Q4 2018 -$133M -$38.6M -$15.6M -68.1% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$117M -$32.7M -$14.5M -80% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$103M -$31.2M -$16.4M -110% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$86.2M -$30.2M -$17.7M -141% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q4 2017 -$68.5M -$22.9M -$11.5M -99.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$57.1M -$18.2M -$7.5M -70.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$49.6M -$14.8M -$1.97M -15.3% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$47.6M -$12.6M +$480K +3.68% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$48.1M -$11.5M -$6.76M -143% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-15
Q3 2016 -$41.3M -$10.7M -$62K -0.58% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$41.3M -$12.9M -$10.3M -396% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$31M -$13M -$10.4M -397% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$20.6M -$4.71M -$2.12M -81.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$18.4M -$10.6M -$7.98M -300% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$10.5M -$2.59M -$365K -16.4% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$10.1M -$2.62M -$1.59M -154% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$8.52M -$2.6M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$2.66M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-23
Q2 2014 -$2.23M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-23
Q1 2014 -$1.03M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.